School of Medicine
Showing 11-20 of 116 Results
-
Jehan Bahrainwala, MD, FASN
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Bahrainwala is a board-certified, fellowship-trained nephrologist with the Stanford Medicine Kidney Clinic and Kidney and Pancreas Transplant Program. She is also a clinical assistant professor in the Department of Medicine, Division of Nephrology.
She diagnoses and treats a wide range of conditions, including blood in the urine, diabetic nephropathy, high blood pressure, and kidney disease. Dr. Bahrainwala is skilled at creating connections with her patients. She treats the whole person rather than the condition and was nominated for The Dr. Vanitha Appadorai Vaidya Award for Humaneness in Medicine by the Philadelphia County Medical Society.
Dr. Bahrainwala has led research on the risks associated with common surgeries performed on patients with chronic kidney disease receiving dialysis. Her work has been published in the American Journal of Kidney Diseases, Kidney International Reports, and other peer-reviewed journals. She has also presented to her peers at national and regional meetings for the American Society of Nephrology, the American Transplant Congress Meeting, the Alliance for Academic Internal Medicine, and the American Heart Association’s Council for High Blood Pressure Research.
Dr. Bahrainwala is a fellow of the American Society of Nephrology and a member of the National Kidney Foundation. -
Xiangqi Bai
Postdoctoral Scholar, Oncology
BioMy research is focused on computational and systems biology. My primary research interest lies in developing new computational algorithms and statistical methods for the analysis of complex data in biological systems, especially related to the large-scale single-cell RNA sequencing data. The specific topics I have examined include:
1. Integration of single-cell multi-omics datasets for tumor
2. Statistical test of cell developmental trajectories
3. Visualization and reconstruction of single-cell RNA sequencing data
4. Computational analysis of the bifurcating event revealed by dynamical network biomarker methods -
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Matthew C. Baker, MD MS
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, Sjogren's syndrome, and rheumatoid arthritis. He also utilizes large databases to study osteoarthritis, with an interest in repurposing existing drugs for the treatment of osteoarthritis.
